News

Filter

1 to 9 of 12 results

Actavis reportedly to be acquired by Watson; debuts generic Zomig

22-03-2012

Icelandic generic drugmaker Actavis is said to be in talks to be acquired by US peer Watson Pharmaceuticals…

ActavisAstraZenecaEuropeGenericsMarkets & MarketingMergers & AcquisitionsNeurologicalPatentsWatson PharmaceuticalsZolmitriptanZomig

Tentative OK from US FDA for Watson's rosuvastatin zinc tablets

10-08-2011

US drugmaker Watson Pharmaceuticals (NYSE: WPI) says that its subsidiary, Watson Laboratories, has received…

AstraZenecaCardio-vascularCrestorGenericsNorth AmericaRegulationrosuvastatinWatson Pharmaceuticals

AstraZeneca sees 3rd-qtr 2010 earnings slump 27%, hit by charges and generic competition; sues Watson

28-10-2010

Generic competition, as well as restructuring and legal costs have taken a hefty toll on AstraZeneca’s…

AstraZenecaCrestorFinancialPatentsPharmaceuticalWatson Pharmaceuticals

US FDA calls for heart/diabetes risk warnings for class of prostate cancer drugs

21-10-2010

The US Food and Drug Administration yesterday asked manufacturers to add new warnings to labeling of…

Abbott LaboratoriesAstraZenecaEligardLupronNorth AmericaOncologyPfizerPharmaceuticalRegulationSanofi-AventisSynarelTrelstarWatson PharmaceuticalsZoladex

1 to 9 of 12 results

COMPANY SPOTLIGHT

Menarini

Back to top